PINATUZUMAB VEDOTIN

UNII:	6KA1906BLC
Formula:
Preferred Substance Name:	PINATUZUMAB VEDOTIN

1313706-14-7
ACD22-VCMMAE
ACD-22VCMMAE
ACD-22-VCMMAE
ANTI-CD22-MONOMETHYL AURISTATIN E ANTIBODY-DRUG CONJUGATE
DCDT2980S
DCDT-2980S
FCU2703
FCU-2703
IMMUNOGLOBULIN G1, ANTI-(HUMAN SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 2) (HUMAN-MUS MUSCULUS MONOCLONAL MCDT2219A HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MCDT2219A .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE
IMMUNOGLOBULIN G1-KAPPA AURISTATIN E CONJUGATE, ANTI-(HOMO SAPIENS CD22 (SIALIC ACID BINDING IG-LIKE LECTIN 2, SIGLEC2, SIGLEC-2, BLYMPHOCYTE CELL ADHESION MOLECULE, BL-CAM, LEU-14)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN E
PINATUZUMAB VEDOTIN [INN]
PINATUZUMAB VEDOTIN [USAN]
PINATUZUMAB VEDOTIN [WHO-DD]
RG-7593
RO5541072-000
RO-5541072000
RO-5541072-000

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PINATUZUMAB VEDOTIN

Synonyms and Mappings

Resources